Press release
Product Registration for OTC, Phyto, substance-based MD, FS & Cosmetics in Mexico: Tips and Tricks to succeed - presented by Chameleon Pharma Consulting Group.
Mexico is the second-largest OTC & pharma market in Latin America, with premium pricing and well-regulated environment by COFEPRIS (MoH). The Mexican market is very attractive to enter for foreign players. Many product segments have premium prices above the EU level.We, Chameleon Pharma Consulting Group, have more than 20 years of commercial, market entry & regulatory experience in Mexico. That is why our experts have prepared a regulatory webinar to take place on Tuesday 10th of May 2022 at 16:00 (CET) to share the latest update on the Mexico registration process about the OTC, Phyto, substance-based MD, FS, Cosmetics and GMP topics.
The Regulatory (30 mins + Q&A) webinar will cover:
• What documents are required by COFEPRIS when it comes to OTC, Phyto, substance-based MD, FS, Cosmetics registration; GMP, pharmacovigilance, clinical studies, bibliographic registration dossiers.
• Latest regulatory changes and news by COFEPRIS influencing the registration
• What are the costs and time duration of the process;
• Normal registration and New Molecule Process (CMN), how they differ regarding the registration process.
• Tips and tricks for a fast registration in Mexico.
If you are looking to expand and developing new business opportunities for your OTC, Phyto, substance-based MD, FS, Cosmetics business into Mexico; you want to better understand the requirements by COFEPRIS; you are interested in fast track registration, CMN-committee, GMP, variations for OTC, Phyto, substance-based MD, FS, and cosmetics in Mexico or just curious in tips & tricks about the registration, then this webinar is right for you!
To register, please email Mrs. Celia Lloves on mako@chameleon-pharma.com, we will send your personal link to the webinar. Also, do not forget to check our website and follow us on social media to stay up-to-date on what other insider topics we will cover next.
Chameleon Pharma Consulting Group
Reiner Christensen
Am Tempelhofer Berg 6
10965 Berlin
Germany
Tel: +49 30 648 35 163
E-Mail: service@chameleon-pharma.com
Web: www.chameleon-pharma.com
We, Chameleon Pharma Consulting Group (CPC), are healthcare experts focused on Systematic Market Entry in Europe, CIS/CEE, Latin America, Asia, US/Canada, and the Middle East. Our more than 20 years of practical experience in 300 successful projects in the self-medication and Rx industry allow us to help pharma and OTC companies enter new markets, develop market entry strategies, create product portfolios for selected markets and overcome regulatory requirements more efficiently. With our knowledge and our extensive network of experts, we can guarantee a dynamic, flexible, and customer-oriented service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Product Registration for OTC, Phyto, substance-based MD, FS & Cosmetics in Mexico: Tips and Tricks to succeed - presented by Chameleon Pharma Consulting Group. here
News-ID: 2614999 • Views: …
More Releases from Chameleon Pharma Consulting
Chameleon Pharma Consulting to present Market Entry Strategies at OTCToolbox Con …
Chameleon Pharma Consulting is a healthcare consulting firm with a focus on the emerging markets in Asia, Latin America, CIS / CEE, US / Canada and the Middle East. We support pharma/OTC companies to enter new markets, develop market entry strategies, select product portfolios for focus markets, overcome regulatory hurdles and much more. With more than 20 years of experience in the pharmaceutical industry and a large network of experts,…

Addressing Covid-19 for your business means to be part of the solution!
Many of our clients are wondering how to best tackle business in LATAM, Asia, Europe, US/Canada and CIS/CEE in light of the current Covid-19 crisis, and what topics to address first.
Seven tips to consider for International OTC, Pharma, and Medical Device Leaders.
In the following, we have put together some thoughts for OTC, Pharma, and Medical Device Leaders for overcoming the Covid-19 crisis. The article might support you to reflect on…
Chameleon Pharma Consulting entwickelt neues „International Market Analysis” …
Internationale Wachstumsstrategien in der Gesundheitsbranche, wie beispielsweise in Consumer Health, Pharma Rx & OTC, Medical Devices, Kosmetik, stehen immer mehr in Abhängigkeit der aufstrebenden Länder. Eine hohe Wachstumsrate lässt sich insbesondere in Lateinamerika, Asien, den GUS- und CEE-Staaten, sowie im Mittleren Osten und in ausgewählten europäischen Segmenten verzeichnen. Mit Blick auf die Zukunft können wir sagen, dass die Emerging Markets in den nächsten 10-20 Jahren die größten Wachstumspotentiale innehaben. Um…
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…